These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9546698)

  • 1. Acute rhabdomyolysis after bezafibrate re-exposure.
    Terrovitou CT; Milionis HJ; Elisaf MS
    Nephron; 1998; 78(3):336-7. PubMed ID: 9546698
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
    Górriz JL; Sancho A; Alcoy E; García-Ramos JL; Pallardó LM
    Nephrol Dial Transplant; 1995 Dec; 10(12):2371-2. PubMed ID: 8808248
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
    Panuccio V; Enia G; Parlongo S; Cutrupi S; Zoccali C
    Nephron; 1996; 73(4):736. PubMed ID: 8856294
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
    Plotkin E; Bernheim J; Ben-Chetrit S; Mor A; Korzets Z
    Nephrol Dial Transplant; 2000 May; 15(5):740-1. PubMed ID: 10809833
    [No Abstract]   [Full Text] [Related]  

  • 5. Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment.
    Morimoto S; Fujioka Y; Tsutsumi C; Masai M; Okumura T; Yuba M; Sakoda T; Tsujino T; Ohyanagi M
    Am J Med Sci; 2005 Apr; 329(4):211-3. PubMed ID: 15832106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
    Weissgarten J; Zaidenstein R; Fishman S; Dishi V; Michovitz-Koren M; Averbukh Z; Golik A
    Perit Dial Int; 1999; 19(2):180-2. PubMed ID: 10357195
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
    Takayama T; Tsuji S; Taki J; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Dec; 21(12):988-9. PubMed ID: 8957627
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
    Venzano C; Cordi GC; Corsi L; Dapelo M; De Micheli A; Grimaldi GP
    Minerva Med; 1990 Dec; 81(12):909-11. PubMed ID: 2280884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rhabdomyolysis due to bezafibrate: a new case].
    Gas JM; Prados MC; Perdiguero M; Rivera F
    Med Clin (Barc); 1992 Feb; 98(4):156-7. PubMed ID: 1552772
    [No Abstract]   [Full Text] [Related]  

  • 10. Bezafibrate induced rhabdomyolysis.
    Kanterewicz E; Sanmartí R; Riba J; Trias I; Autonell J; Brugués J
    Ann Rheum Dis; 1992 Apr; 51(4):536-8. PubMed ID: 1586257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bezafibrate-induced rhabdomyolysis.
    Malnick SD; Badir A; Landau Z
    DICP; 1991; 25(7-8):869-70. PubMed ID: 1949949
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function changes in diabetic nephropathy induced by bezafibrate.
    Bruce R; Daniels A; Cundy T
    Nephron; 1996; 73(3):490. PubMed ID: 8832617
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
    Haubenstock A; Schmidt P; Zazgornik J; Balcke P; Kopsa H; Sertl K
    Dtsch Med Wochenschr; 1984 Jan; 109(4):157-8. PubMed ID: 6692783
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin potentiation with bezafibrate.
    Beringer TR
    Postgrad Med J; 1997 Oct; 73(864):657-8. PubMed ID: 9497982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed bezafibrate-induced angio-oedema in a 68-year-old man.
    Frendo M; Theuma R; Fava S
    Br J Clin Pharmacol; 2007 Oct; 64(4):560-1. PubMed ID: 17610533
    [No Abstract]   [Full Text] [Related]  

  • 16. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
    Kamaliah MD; Sanjay LD
    Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome associated with bezafibrate.
    Sawamura D; Umeki K
    Acta Derm Venereol; 2000; 80(6):457. PubMed ID: 11243650
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery time in a case of gemfibrozil and simvastatin-associated rhabdomyolysis.
    Cummins D; Mackey M; Baker E
    South Med J; 2009 Aug; 102(8):858-60. PubMed ID: 19593291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated blood concentrations of cyclosporine and kidney failure after bezafibrate in renal graft recipient.
    Hirai M; Tatuso E; Sakurai M; Ichikawa M; Matsuya F; Saito Y
    Ann Pharmacother; 1996; 30(7-8):883-4. PubMed ID: 8826580
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bezafibrate-induced myoglobinuric kidney failure in a 54-year-old patient with diabetes mellitus type IIa].
    Cissewski K; Kienast K; Windeck R; Benker G; Reinwein D
    Med Klin (Munich); 1988 Mar; 83(5):174-7. PubMed ID: 3374444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.